跳至主要内容
临床试验/NCT01172782
NCT01172782已完成不适用

The Analgesic Effect of Intrathecal Hydromorphone Injection on Spinal Anesthesia

Korea University Anam Hospital0 个研究点目标入组 60 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
60
主要终点
Visual Analgesic Numberic Score

研究概览

简要总结

The purpose of this study is to evaluate the adequate dose of intrathecal hydromorphone injection for postoperative pain relief after knee arthroscopic surgery.

详细描述

Sixty patients who were undergoing unilateral knee arthroscopy randomly received unilateral spinal anesthesia with 0.5% hyperbaric bupivacaine 6 mg combined with normal saline 0.05 mL or hydromorphone 2.5, 5 or, 10 μg/0.05 mL. The verbal numerical rating scale (VNRS) pain scores were measured at 30 minutes and 2, 4, 6, 12 and 24 hours postoperatively, and the side effects of hydromorphone were recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 72 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA class I-II (age range: 18-72 years)
  • Informed consent obtained patients

排除标准

  • The exclusion criteria included evidence of neurological or neuromuscular disease, respiratory or cardiac disease, diabetes mellitus or peripheral neuropathy, as well as those patients who were receiving chronic analgesic therapy or who had infection at the intended site of spinal needle insertion or who had hypersensitivity to amide local anesthetics or opioids

研究组 & 干预措施

control group

Placebo Comparator

control group (CG) received 6 mg of hyperbaric bupivacaine and 0.05 mL of saline.

干预措施: Hydromorphone (Drug)

2.5 ug hydromorphone recieved group

Active Comparator

the 2.5 μg hydromorphone group (2.5HG) received 1.2 (6 mg) mL of 0.5% hyperbaric bupivacaine and 2.5 μg of hydromorphone in 0.05 mL of saline

干预措施: Hydromorphone (Drug)

5 μg hydromorphone group

Active Comparator

5 μg hydromorphone group received 1.2 mL of 0.5% hyperbaric bupivacaine and 5 μg of hydromorphone in 0.05 mL of saline

干预措施: Hydromorphone (Drug)

the 10 μg hydromorpnone group

Active Comparator

the 10 μg hydromorphone group received 1.2 mL of 0.5% hyperbaric bupivacaine and 10 μg of hydromorphone in 0.05 mL of saline.

干预措施: Hydromorphone (Drug)

结局指标

主要结局

Visual Analgesic Numberic Score

时间窗: during postoperative recovery period.

次要结局

未报告次要终点

研究者

申办方类型
Other

相似试验